Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor.
about
Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytesViral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus interacts with a cell death regulator, GRIM19, and inhibits interferon/retinoic acid-induced cell death.Activation of DNA Damage Response Induced by the Kaposi's Sarcoma-Associated Herpes VirusHost epigenetic modifications by oncogenic virusesMulti-step regulation of innate immune signaling by Kaposi's sarcoma-associated herpesvirusCoactivator p300 acetylates the interferon regulatory factor-2 in U937 cells following phorbol ester treatmentTat-controlled protein acetylationKaposi's Sarcoma–Associated Herpesvirus Immunoevasion and Tumorigenesis: Two Sides of the Same Coin?Host transcript accumulation during lytic KSHV infection reveals several classes of host responsesMolecular biology of KSHV in relation to AIDS-associated oncogenesis.Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus binds to p53 and represses p53-dependent transcription and apoptosis.Human T-lymphotropic virus type 1 p30(II) regulates gene transcription by binding CREB binding protein/p300.Parvovirus nonstructural proteins induce an epigenetic modification through histone acetylation in host genes and revert tumor malignancy to benignancy.Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication.Cytokine-induced tumor suppressors: a GRIM storyShort duration of elevated vIRF-1 expression during lytic replication of human herpesvirus 8 limits its ability to block antiviral responses induced by alpha interferon in BCBL-1 cells.Inhibition of the ATM/p53 signal transduction pathway by Kaposi's sarcoma-associated herpesvirus interferon regulatory factor 1.GRIM-19: A Double-edged Sword that Regulates Anti-Tumor and Innate Immune Responses.Immune evasion by Kaposi's sarcoma-associated herpesvirus.Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesisCooperation between viral interferon regulatory factor 4 and RTA to activate a subset of Kaposi's sarcoma-associated herpesvirus lytic promotersThe diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases.Modulation of Immune System by Kaposi's Sarcoma-Associated Herpesvirus: Lessons from Viral Evasion Strategies.Viral interferon regulatory factors decrease the induction of type I and type II interferon during rhesus macaque rhadinovirus infection.A Rhesus Rhadinovirus Viral Interferon (IFN) Regulatory Factor Is Virion Associated and Inhibits the Early IFN Antiviral Response.The viral interferon regulatory factors of KSHV: immunosuppressors or oncogenes?Modulation of the cGAS-STING DNA sensing pathway by gammaherpesvirusesRegulation of growth signalling and cell cycle by Kaposi's sarcoma-associated herpesvirus genes.Epigenetic mechanisms in virus-induced tumorigenesis.Negative regulation of transcription coactivator p300 by orphan receptor TR3.Viral Interferon Regulatory Factor 1 of Kaposi's Sarcoma-Associated Herpesvirus Interacts with a Translocation Liposarcoma Protein-Associated Serine-Arginine Protein.Viral manipulation of the host epigenome for oncogenic transformation.Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus replication.Viral interferon regulatory factors.Overlapping CRE and E box motifs in the enhancer sequences of the bovine leukemia virus 5' long terminal repeat are critical for basal and acetylation-dependent transcriptional activity of the viral promoter: implications for viral latency.Evasion and subversion of interferon-mediated antiviral immunity by Kaposi's sarcoma-associated herpesvirus: an overview.Histone modifications in herpesvirus infections.The chromatin landscape of Kaposi's sarcoma-associated herpesvirus.Review of latent and lytic phase biomarkers in Kaposi's sarcoma.
P2860
Q24537686-D22088A6-5EE7-4352-8274-54CFE0A464E2Q24538223-0D667306-97C1-4BC9-842A-95DC765E38E8Q26743368-1CEA135C-2E10-4301-A23F-924CD926F23EQ27485909-3B55AAA0-AC8C-4E64-BEC5-5FDBF37AC966Q28080550-77FD036A-A25F-4B9A-BBCF-B08ABC8D439EQ28212641-17B73EA5-D239-46A8-9933-53120A928EF3Q28216737-98829AAE-CAA6-4374-8E83-FC29DF8D378CQ29394711-ABAFEF2B-86F3-486F-95FC-315D5E5964ECQ33295395-F9301EA9-877A-4707-8E51-5CD1A11B9284Q33560572-C07F85D4-E75F-42F2-8F4F-A679A0E53EAEQ33842636-064B7DAB-ECDF-4649-9442-AFC0C4CBD743Q33846963-48647260-6301-4F2B-9E67-D668B161AF3DQ33884051-C90FE982-5A60-45D6-9909-C061F3DDAFF9Q34013830-586F1184-CDA9-433D-9707-4694901ACA10Q34077445-033AEBB3-2AE5-4A06-BD56-D2A29B755D22Q34192731-F0380FA4-227F-444E-B312-150033F1DD65Q34434681-774EAF5C-3217-4EE1-85F8-90866C48BF07Q34497752-517A406F-C9CA-4BEB-A5D0-5D39B7156F83Q34795543-5338AF71-9F58-478D-986B-9D8994862139Q35026060-8EC93561-58FA-4757-BEC3-31E0CC82DFD1Q35124404-1E647915-2232-4AA6-AF67-B0AD97445D29Q35665832-1B858B2B-AC52-4BB9-818B-BFF1B4AEB849Q35666251-6937D509-D775-45AC-A5CE-EA116B7E9D90Q35801076-025AD78A-2802-484B-8C27-B95D73232640Q35826613-814D44EC-FBDF-4D26-9698-C8521AFC919DQ35861143-38D4AF58-6FAF-4AA5-8879-B6C6FE87CC5DQ35927496-4AA6F828-BC1D-4008-B2C5-CEFF479A4FF5Q35946145-D6FEA14B-D2BA-4F93-A1A5-BDDC55FF5012Q35964857-F43A9FC2-376C-46F5-AF12-F827E9FB3EBEQ36001887-5BD797D3-0137-4883-AB82-18FB42006F24Q36328939-BE3A55EC-5889-42E4-B806-2F87C7170E90Q37083091-F857647E-38E4-434D-A1CE-4CE660E86068Q37217317-84BB8330-4E58-49FA-9C32-78D7FEB60DBDQ37476243-381B2CBF-CC30-4DBF-8BC0-6A73D579FD85Q37588733-664E6E02-406D-42B9-826F-DE6526BD2EA7Q37683398-0F7AA805-58CE-4B00-8FB5-AC5561BAAAB1Q37903168-2934FA17-B56F-40EA-A28F-CA66C0E7EBF7Q37970405-E562A419-641E-40D1-B796-A72FF509CC64Q38108700-8DCDD881-B7A5-45E6-9FCB-EF7ECB072208Q38144129-EF5C903B-9B3B-461A-9A0E-7F9B85BAB198
P2860
Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor.
@ast
Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor.
@en
type
label
Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor.
@ast
Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor.
@en
prefLabel
Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor.
@ast
Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor.
@en
P2093
P2860
P1476
Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor.
@en
P2093
P2860
P304
P356
10.1128/MCB.20.21.8254-8263.2000
P407
P577
2000-11-01T00:00:00Z